(CNN) – The United States Department of Medicines and Food Administration (FDA, by its seal in English) authorizes the emergency use of the vaccine against Johnson & Johnson’s covid-19 for 18-year-old adults. It is the third vaccine authorized by the FDA, and is the first available in the country that requires a single dose.
The vacancy, manufactured by Janssen, the vacancy framework of J&J, is secure and effective and does not require special specialization, which allows a more easy distribution throughout the country.
The Johnson & Johnson vaccine has been tested by more than 44,000 people in EE.UU., South Africa and Latin America. At the global level, there is an impact of 66.1% against the covid-19 of moderate to serious / critical at least four weeks after the evacuation, following an analysis by the FDA. In EE.UU., it is considered to have an efficiency of 72% and offers an protection of 86% against the serious forms of illness.
Dr. Janet Woodcock, FDA Commissioner, tuiteó: “The authorization of this vaccine extends to the availability of vaccines, the best method of contraception for covid-19, to help in the face of this pandemic, which has covered more than a million lives in the United States”.
The Domingo, the Assessors Committee on the Practice of Immunization of the Control Centers for Prevention of Enema, known as ACIP, will meet to establish the directives on which they should receive the vaccine. The vote will take place at 15:00 ET.
From here on out, the vacancy can be distributed to all vacation centers throughout the country. The federal governing dice that is listed to distribute up to 4 million doses of the intermediate manner vaccine.